Table 3 Study design 36 month duration of immunity
Treatment Group | Test Article (TA) | Dose Volume TA | Days of TA Admin | Route of TA | Day of FeLV Challenge | Volume/ Route of Challenge | Number of Animals |
|---|---|---|---|---|---|---|---|
T07 | Water for Injection | 1 mL | 0, 21 | SC | 1143 | 1 mL/IP | 11 |
T08 | Versifel FeLV | 1 mL | 0, 21 | SC | 1143 | 1 mL/IP | 16 |
T09 | - | - | - | - | 1143 | 1 mL/IP | 6 |